IRIS
SVEGLIATI BARONI, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.225
EU - Europa 2.393
AS - Asia 1.789
SA - Sud America 599
AF - Africa 91
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
AN - Antartide 1
Totale 9.111
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.152
SG - Singapore 607
BR - Brasile 507
UA - Ucraina 427
CN - Cina 377
IT - Italia 314
SE - Svezia 292
DE - Germania 285
RU - Federazione Russa 253
IE - Irlanda 238
VN - Vietnam 215
TR - Turchia 208
HK - Hong Kong 180
DK - Danimarca 155
FI - Finlandia 113
GB - Regno Unito 97
FR - Francia 96
KR - Corea 86
CA - Canada 44
AR - Argentina 33
CI - Costa d'Avorio 32
PL - Polonia 28
IN - India 27
MA - Marocco 22
MX - Messico 20
ID - Indonesia 19
AT - Austria 18
BE - Belgio 18
ZA - Sudafrica 18
EC - Ecuador 17
BD - Bangladesh 16
ES - Italia 14
NL - Olanda 14
CO - Colombia 13
JP - Giappone 11
LT - Lituania 11
PY - Paraguay 10
TN - Tunisia 7
VE - Venezuela 7
EU - Europa 6
IQ - Iraq 6
PK - Pakistan 6
AU - Australia 5
EG - Egitto 5
RS - Serbia 5
SA - Arabia Saudita 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 3
EE - Estonia 3
KZ - Kazakistan 3
LB - Libano 3
OM - Oman 3
UZ - Uzbekistan 3
AL - Albania 2
BG - Bulgaria 2
CL - Cile 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
IL - Israele 2
NI - Nicaragua 2
PE - Perù 2
RO - Romania 2
SN - Senegal 2
SR - Suriname 2
AF - Afghanistan, Repubblica islamica di 1
AQ - Antartide 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CW - ???statistics.table.value.countryCode.CW??? 1
DZ - Algeria 1
ET - Etiopia 1
GT - Guatemala 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
MD - Moldavia 1
MW - Malawi 1
NA - Namibia 1
NP - Nepal 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.111
Salva come PNG Salva come JPEG
Città #
Chandler 604
Jacksonville 434
Ashburn 421
Singapore 386
Boardman 239
Dublin 235
Dallas 190
Fairfield 183
Hong Kong 180
New York 149
Beijing 138
Wilmington 137
Lawrence 93
Princeton 93
Centro 87
San Mateo 87
Woodbridge 86
Ho Chi Minh City 84
Los Angeles 83
Des Moines 81
Ann Arbor 79
Houston 76
The Dalles 75
Munich 61
São Paulo 59
Seattle 58
Hefei 55
Moscow 54
Cambridge 49
Hanoi 44
Buffalo 43
San Diego 33
Turin 32
Abidjan 31
Ancona 31
London 25
Warsaw 25
Turku 21
Nuremberg 19
Rio de Janeiro 18
Montreal 17
Brussels 16
Chicago 16
San Francisco 15
Guangzhou 14
Helsinki 14
Orem 14
Stockholm 14
Poplar 13
Santa Clara 13
Denver 12
Washington 12
Atlanta 11
Da Nang 11
Izmir 11
Johannesburg 11
Marche 11
Shanghai 11
Belo Horizonte 10
Boston 10
Chennai 10
Mexico City 9
Phoenix 9
Pune 9
Tokyo 9
Wuhan 9
Juneau 8
Milan 8
Monte San Pietrangeli 8
Porto Alegre 8
Redmond 8
Toronto 8
Ankara 7
Brooklyn 7
Guarulhos 7
Amsterdam 6
Biên Hòa 6
Brasília 6
Bắc Ninh 6
Columbus 6
Council Bluffs 6
Curitiba 6
Goiânia 6
Guayaquil 6
Haiphong 6
Itaquaquecetuba 6
Jesi 6
Jinhua 6
Ottawa 6
Vienna 6
Belgrade 5
Bologna 5
Caxias do Sul 5
Charlotte 5
Falls Church 5
Hải Dương 5
Manchester 5
Montevideo 5
Quận Một 5
Quận Phú Nhuận 5
Totale 5.398
Salva come PNG Salva come JPEG
Nome #
Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti−Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies 166
Metabolomic profile of systemic sclerosis patients 153
Decreased serum levels of the inflammaging marker miR-146a are associated with clinical response to tocilizumab in COVID-19 patients 148
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease–associated spondyloarthritis 142
Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach 140
c-MYB transactivates the alpha 2(I) collagen gene. 139
A reactive Oxygen species -mediated loop mantains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis 138
Agonistic anti-PDGF receptor autoantibodies from patients with systemic sclerosis impact human pulmonary artery smooth muscle cells function in vitro 137
ALTERATIONS OF ROS PATHWAYS IN SCLERODERMA BEGIN AT STEM CELL LEVEL 135
Epitope specificity determines pathogenicity and detectability of anti-platelet-derived growth factor receptor α autoantibodies in systemic sclerosis 135
B CELL RECEPTOR EDITING IN SCLERODERMA PATIENTS GENERATES PATHOGENIC ANTI-PDGFR AUTOANTIBODIES 130
Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice 128
Activation in vitro of scleroderma skin fibroblasts is sustained by increased generation of free radicals through the NADPH-oxidase pathway. 126
The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib 125
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 124
Long lasting biological effects of PDGFR agonistic auto-antibodies in scleroderma 122
Bone formation by distraction clinical and structural studies 122
Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel Disease 122
DETECTION OF STIMULATORY ANTI-PDGF RECEPTOR AUTOANTIBODIES BY BIOASSAYS BASED ON DIFFERENT CELL LINES 118
Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK 1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts 115
Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis 112
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 110
Characterization of the c-Myb-responsive region and regulation of the human type I collagen α2 chain gene by c-Myb 110
Ha-Ras/ERK1-2 pathway is responsable for oxygen species generation by scleroderma skin fibroblasts 109
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD 109
Agonistic antibodies in systemic sclerosis 108
Circulating miR-320b and miR-483-5p levels are associated with COVID-19 in-hospital mortality 107
Cloning of agonistic autoantibodies specific for the PDGF receptor from the B-cell repertoire of SSc patients 106
AUTOIMMUNITY TO PDGFR: A RELEVANT PATHOGENIC LINK IN SSc 104
The long pentraxin PTX3 is a marker of scleroderma fibroblasts activation 102
Stimulatory autoantibodies against PDGF receptors in Scleroderma 100
The Wnt signalling inhibitor gene, WIF1, is silenced in fibroblasts derived from Systemic Sclerosis patients: role of oxidative stress 100
Intracellular free radical production by peripheral blood T lymphocytes from patients with systemic sclerosis: Role of NADPH oxidase and ERK1/2 100
WIF1, A WNT PATHWAY INHIBITOR, IS SILENCED IN SYSTEMIC SCLEROSIS BY DNA DAMAGE: A MECHANISM LINKING DNA DAMAGE TO WNT AND FIBROSIS 98
Autoantibodies against the platelet-derived growth factor receptor in scleroderma: comment on the articles by Classen et al and Loizos et al. 98
Mechanism of action of agonistic PDGFR auto-antibodies isolated from scleroderma patients 98
Patients with chronic extensive GvHD produce high levels of stimulatory auto-antibodies to the PDGF receptor: a new pathophysiological pathway of the disease progression 98
Pathogenic autoantibodies in systemic sclerosis 97
CLONING OF AGONISTIC AUTOANTIBODIES SPECIFIC FOR THE PDGF RECEPTOR FROM THE B CELL REPERTOIRE OF PATIENTSAFFECTED BY SYSTEMIC SCLEROSIS 97
Stimulating autoantibodies to PDGF A/B receptor on sera from scleroderma patients 95
Stimulatory autoantibodies against PDGF receptor in serum from patients with GVHD and scleroderma-like changes 95
NADPH oxidase, oxidative stress and fibrosis in systemic sclerosis 95
Reduced type I collagen gene expression by skin fibroblasts of patients with systemic sclerosis after one treatment course with rituximab 94
Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis 94
Coenzyme Q homologs and vitamin E in synaptic and non-synaptic occipital cerebral cortex mitochondria in the ageing rat. 93
Putative functional pathogenic autoantibodies in systemic sclerosis 93
Solid monounsaturated diet lowers LDL unsaturation trait and oxidisability in hypercholesterolemic (type IIb) patients 91
Dietary restriction affects antioxidant levels in rat liver mitochondria during ageing 91
Isolation and cloning of stimulatory anti-PDGF receptor auto-antibodies from the immunological repertoire of patients with systemic sclerosis 91
Ha-Ras/ERK1-2 pathway is responsible for oxygen species generation in scleroderma fibroblasts 91
Stimulatory autoantibodies against PDGF receptor in systemic sclerosis 90
Oxidative DNA damage induces the ATM-mediated transcriptional suppressionof the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis 90
Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvemen 89
Scleroderma fibroblasts constitutively express the long pentraxin PTX3. 88
Oxidative stress and the pathogenesis of scleroderma: the Murrell's hypothesis revisited. 86
PDGF receptor as therapeutic and diagnostic target in systemic sclerosis 86
Coenzyme Q homologs and Vitamin E in synaptic and non-synaptic occipital cerebral cortex mitochondria in the aging rat 86
Scleroderma-like fibrosis in chronic graft-vs-host disease is sustained by anti-PDGF receptors antibodies 85
Tissue-targeted antifibrotic gene therapy using a transgene driven by the promoter of the human type I collagen gene 85
Biological effects of serum immunoglobulins from scleroderma patients on human pulmonary artery smooth muscle cells. Role of NOX4 and ROS 85
Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets 85
Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches 85
Dietary restriction affects antioxidant levels in rat liver mitochondria diuring aging 84
PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis 84
Adeno-associated virus type 5 infection via PDGFRα is associated with Interstitial lung disease in systemic sclerosis and generates composite peptides and epitopes recognized by the agonistic immunoglobulins present in patients with systemic sclerosis 83
The Wnt signalling inhibitor gene, WIF-1, expression is downregulated in fibroblasts derived from systemic sclerosis patients by a persistent oxidative stress 83
Association between TNF-α, cortisol levels, and exposure to PM10 and PM2.5: a pilot study 82
The treatment of UCD200 and scleroderma fibroblasts with siRNAs anti-C-MYB blocks type I collagen transcription: Toward a gene therapy of scleroderma 82
Stimulatory Auto-Antibodies To The PDGF Receptor As Pathology Marker And Therapeutic Target 81
Monounsaturated diet lowers LDL oxidisability in type IIb and type IV dyslipidemia without affecting coenzyme Q10 and vitamin E contents 81
Treatment With Rituximab Reduces Activation Of Scleroderma Dermal Fibroblasts 80
H-Ras but not K-Ras is responsible for reactive oxygen species generation by scleroderma skin fibroblasts. 80
Oxidative stress in scleroderma - Maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway 78
Development of a Skin-Humanized Model as a Novel Tool to Investigate the Pathogenesis of Scleroderma 77
Stimulatory auto-antibodies to the PDGF receptor in patients with chronic GVHD. 77
Isolation and cloning of stimulatory anti-PDGF receptor auto-antibodies from the immunological repertoire of patients with systemic sclerosis 76
Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients 76
Lipid raft colocalization of PDGFR-NADPH complex and receptor integrity are important for the activation of the intracellular signaling by scleroderma IgG in normal human fibroblasts 75
Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis 72
Rituximab for the treatment of cutaneous involvement in systemic sclerosis. evidence for a pathogenetic role of B-CELLS 72
Unbalance between Ha- and Ki-Ras is responsible for scleroderma fibroblast activation 71
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 70
Stimulatory autoantibodies to the PDGF receptor in scleroderma (Correspondence) 69
The important role of molecular analyses to evaluate the efficacy of Rituximab treatment in a patient affected by severe multineuropathy in mixed cryoglobulinemia disease. 69
Reactive oxygen species are required for manteinance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis. 69
Stimulatory autoantibodies against PDGF receptor in serum from patients with GVHD and scleroderma-like changes. 68
Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of free radical generation through the NADPH oxidase complex pathway 67
Epitopes of the human PDGF receptor able to bind human auto-antibodies, antibodies and uses thereof 67
Restricted immunoglobulin repertoire and evolutionary mechanism of PDGFR-autoreactive memory B cells in systemic sclerosis 65
STIMULATORY AUTOANTIBODIES AGAINST PDGF RECEPTOR IN A LARGE COHORT OF ITALIAN SCLERODERMA PATIENTS 64
Monounsaturated diet lowers LDL oxidisability in type IIb and type IV dyslipidemia without affecting coenzyme Q10 and vitamin E contents 62
Restricted immunoglobulin repertoire and evolutionary mechanism of PDGFR-autoreactive memory B cells in systemic sclerosis 60
Screening and Analysis of Possible Drugs Binding to PDGFRα: A Molecular Modeling Study 56
Intracellular free radical production by peripheral blood T lymphocytes from patients with Systemic Sclerosis: role of NADPH oxidase and ras 56
New insights into the role of oxidative stress in scleroderma fibrosis. 55
Skin Gene Expression Profiles in Systemic Sclerosis: From Clinical Stratification to Precision Medicine 51
Dietary olive oil affects LDL peroxidability in hypercholesterolemic (IIB) patients 50
Expression profile and regulation of NOX proteins in Systemic Sclerosis 46
Totale 9.229
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.238
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.238
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021555 0 0 0 0 0 55 99 44 129 67 120 41
2021/2022614 36 169 9 32 11 24 14 56 42 32 51 138
2022/20231.530 134 188 110 161 138 202 6 98 366 9 82 36
2023/2024752 140 29 40 125 127 170 9 12 0 15 6 79
2024/20251.553 149 145 68 12 93 18 174 43 353 103 168 227
2025/20262.333 379 491 235 502 467 259 0 0 0 0 0 0
Totale 9.229